In a type of study design known as a crossover, patients received their allotted pill (either Ampyra or placebo) for two weeks twice daily, then all switched to placebo.
Unlike two-way, three-way, four-way or so-called "hybrid" armature driver (hearing aid type) earphones, there are no electronic or comb filtering artifacts, no phase issues, and no crossover dropouts.